What happened when one patient treated GLP-1 not as a shortcut but as a catalyst My patient, Latha, had Type 2 diabetes and was on daily insulin shots
Recent regulatory developments further illustrate the growing relevance of this issue as the FDAs Pharmacy Compounding Advisory Committee (PCAC) is set to review seven peptides for potential inclusion on the Section 503ABulks List including BPC-157, KPV, TB-500, MOTS-c, DSIP (Emideltide), Semax, and Epitalon
We're here to provide a clear, authoritative framework based on our collective experience in synthesizing and handling these compounds for years
One study warns that these drugs produce unsustainable volumes of toxic waste and non-degradable solid supports ( [20] ), prompting CDMOs to pursue greener chemistries and solvent-recovery systems (for example, water-based or continuous SPPS) as part of future-capex planning ( [21] ) ( [20] )
If youre considering or already starting a GLP-1, I can help you build a plan that keeps your ADHD treatment effective while protecting your overall health